Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma

International Journal of Hematology

Volumn 86, Issue 2, 2007, Pages 118-125

  Okamura, Jun ^a   Uike, Naokuni ^a   Utsunomiya, Atae ^b   Tanosaki, Ryuji ^c  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b IMAMURA BUN IN HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

alloSCT; ATLL; HTLV 1 proviral load; RIST

Indexed keywords

BUSULFAN; CYCLOSPORIN A; FLUDARABINE; GANCICLOVIR; THYMOCYTE ANTIBODY;

ALLOGENEIC STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHIMERA; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; REVIEW; T CELL LEUKEMIA; T CELL LYMPHOMA; UNSPECIFIED SIDE EFFECT; VIRUS LOAD;

AGED; AGED, 80 AND OVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 34548779113     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.07070     Document Type: Review

References (19)

1. Tsukasaki K, Maeda T, Arimura K, et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature. Bone Marrow Transplant. 1999;23:87-89.
2. Yamada Y, Tomonaga M, Fukuda H, et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol. 2001;113:375-382.
3. Utsunomiya A, Miyazaki Y, Takatsuka Y, et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:15-20.
4. Kami M, Hamaki T, Miyakoshi S, et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol. 2003;120:304-309.
5. Fukushima T, Miyazaki Y, Honda S, et al. Allogeneic hematopoietic stem-cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia. 2005;19:829-834.
6. Okamura J, Utsunomiya A, Tanosaki R, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood. 2005;105:4143-4145.
7. The Japan Society for Hematopoietic Cell Transplantation. Annual Report of Nationwide Survey 2006. Nagoya, Japan: The Japan Society for Hematopoietic Cell Transplantation Office of Nationwide Survey; 2006.
8. Sobue R, Yamauchi T, Miyamura K, et al. Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation. Bone Marrow Transplant. 1987;2:441-444.
9. Tamaki H, Matsuoka M. Donor-derived T-cell leukemia after bone marrow transplantation. N Engl J Med. 2006;354:1758-1759.
10. Nakase K, Hara M, Kozuka T, et al. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma. Bone Marrow Transplant. 2006;37:41-44.
11. Kato K, Kanda Y, Eto T, et al. Allogeneic bone marrow transplantation from unrelated HTLV-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program. Biol Blood Marrow Transplant. 2007; 13: 90-99.
12. Wake A, Kato D, Takagi S, et al. Reduced-intensity cord blood transplantation (RICBT) is a feasible approach for advanced adult T-cell leukemia (ATL) [abstract]. Blood. 2005;106. Abstract 5448.
13. Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 1998;91:756-763.
14. Khouri IF, Keating M, Korbling M, et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 1998;16:2817-2824.
15. Sonoda J, Koriyama C, Yamamoto S, et al. HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking. Cancer Sci. 2004;95:596-601.
16. Abe Y, Yashiki S, Choi I, et al. Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin. Int J Hematol. 2002;76:91-93.
17. Harashima N, Kurihara K, Utsunomiya A, et al. Graft-versus-human Tax response in adult T cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 2004;64:391-399.
18. Kannagi M, Harashima N, Kurihara K, et al. Tumor immunity against adult T-cell leukemia. Cancer Sci. 2005;96:249-255.
19. Fujiwara H, Kawada H, Matsushita K, et al. Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donor. Int J Hematol. 2005;82:357-361.